Acadia Pharmaceuticals Expands Portfolio with Late-Stage Development Candidate for Prader-Willi Syndrome
☀️Trending News Acadia Pharmaceuticals ($NASDAQ:ACAD) has announced the addition of a late-stage development candidate to their portfolio. The candidate, called [...]
ACADIA Pharma Misses Expectations with GAAP EPS of -$0.27 and Revenue of $118.46M
Trending News 🌧️ The company reported a GAAP earnings per share of -$0.27, which was $0.06 below expectations. Revenue also [...]
ACADIA Pharmaceuticals CEO Stephen Davis Sells 7,806 Shares in Recent Transaction
Trending News ☀️ ACADIA ($NASDAQ:ACAD) Pharmaceuticals Inc. is a biopharmaceutical company based in San Diego, California. The company focuses on [...]
Acadia Pharmaceuticals Intrinsic Value Calculation – Global Investment Firm Allspring Boosts Stake in ACADIA Pharmaceuticals to $149000
Trending News ☀️ ACADIA ($NASDAQ:ACAD) Pharmaceuticals Inc. has received a major boost in investment from Allspring Global Investment Holdings LLC, [...]
Acadia Pharmaceuticals Stock Fair Value – ACADIA Pharmaceuticals Poised for Growth in 2023
Trending News ☀️ ACADIA ($NASDAQ:ACAD) Pharmaceuticals Inc. (NASDAQ: ACAD) is a pharmaceutical company focused on the discovery, development, and commercialization [...]
Acadia Pharmaceuticals Sees a 5.0% Jump in Share Price, with Optimistic Outlook for 2023 Earnings Estimates.
Trending News ☀️ Acadia Pharmaceuticals ($NASDAQ:ACAD) saw a significant jump in their share price last session, increasing by 5.0%. This [...]
ACADIA PHARMACEUTICALS Reports Positive Q4 Earnings with 3.2% Revenue Increase for 2022
Earnings Overview On February 28 2023, ACADIA PHARMACEUTICALS ($NASDAQ:ACAD) released their fiscal year 2022 fourth quarter earnings results, which showed [...]
ACADIA Pharmaceuticals Reports Q4 2023 GAAP EPS of -$0.26, Missing Expectations By $0.02.
Trending News 🌧️ ACADIA ($NASDAQ:ACAD) Pharmaceuticals recently reported the GAAP results from Q4 2023, revealing an earnings per share of [...]
Ranting About ACADIA Pharmaceuticals Inc: What You Need to Know
Trending News 🌥️ ACADIA ($NASDAQ:ACAD) Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing treatments for central nervous [...]
Acadia Pharmaceuticals Stock Fair Value Calculation – Acadia Pharmaceuticals Pioneers Innovative Medicines for CNS Disorders, with Nuplazid and Trofinetide in the Pipeline.
Trending News ☀️ Acadia Pharmaceuticals Stock Fair Value Calculation - Acadia Pharmaceuticals ($NASDAQ:ACAD) is dedicated to developing innovative medicines that [...]
